Riskpilot← Back to searchSign inGet full accessGENEE ApS
APSActiveCVR 34887918Sirius Alle 49Engineering activities and related technical consultancy · NACE 7112Est. 2012— employees
Revenue 2024
DKK -10K
-3% vs 2023
EBITDA margin
100.0%
+3% vs 2023
Equity ratio
86.9%
Financial strength
Net profit 2024
DKK 54K
-45% vs 2023
| Revenue | DKK -10K | -3% |
| EBITDA | DKK -10K | +3% |
| Net profit | DKK 54K | -45% |
| Total assets | DKK 155K | -64% |
| Equity | DKK 135K | -30% |
| Employees | — | — |
Legal name
GENEE ApS
CVR number
34887918
Legal form
Anpartsselskab
NACE code
7112 · Engineering activities and related technical consultancy
Founded
14. december 2012
Share capital
DKK 80.000
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren
Company purpose
Selskabets formål er at drive konsulentvirksomhed indenfor biotek samt eje ejerandele af andre selskaber.
Address
Sirius Alle 49
Phone
+4529803018
Email
hansgenee@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -9 | 145 | 375 | 0 | -13 | -7 | -7 | -7 | -8 | -8 | -10 | -10 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -9 | 145 | 375 | -11 | -13 | -7 | -7 | -7 | -8 | -8 | -10 | -10 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -9 | 145 | 375 | -11 | -13 | -7 | -7 | -7 | -8 | -8 | -10 | -10 |
| Net financials | -14 | 54 | -2 | -14 | 38 | -8 | 27 | 32 | 107 | 36 | 136 | 80 |
| Profit before tax | -23 | 198 | 373 | -25 | 26 | -16 | 20 | 25 | 99 | 29 | 126 | 70 |
| Tax | -0 | 33 | 88 | -0 | 1 | -0 | 4 | 5 | 19 | 7 | 28 | 16 |
| Net profit | -23 | 165 | 285 | -25 | 24 | -16 | 16 | 19 | 80 | 22 | 98 | 54 |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 64 | 304 | 559 | 390 | 317 | 246 | 247 | 245 | 938 | 344 | 431 | 155 |
| Equity | 57 | 222 | 457 | 382 | 305 | 240 | 201 | 110 | 190 | 213 | 193 | 135 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 7 | 82 | 102 | 8 | 12 | 6 | 46 | 134 | 747 | 131 | 238 | 20 |
| Total debt | 7 | 82 | 102 | 8 | 12 | 6 | 46 | 134 | 747 | 131 | 238 | 20 |
EBITDA margin
-957500.0%
This company
15.8%
Market median
-6060227% vs market
20132024
Equity ratio
86.9%
This company
38.2%
Market median
+127% vs market
20132024
Return on equity
40.2%
This company
18.4%
Market median
+118% vs market
20132024
Net profit margin
5424300.0%
This company
8.1%
Market median
+66966567% vs market
20132024
Asset turnover
-0.06×
This company
1.12×
Market median
-105% vs market
20132024
Debt / equity
0.15×
This company
0.62×
Market median
+76% vs market
20132024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2012-12-14 – 2013-12-31
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2012 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of GENEE ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|